VS
stockvs
Go to ScreenerHub
ABBV

ABBV vs JNJ

JNJ

In the past 12 months, JNJ returned +47% while ABBV gained 17%.

ABBV
ABBV

AbbVie Inc.

$217.58
6.7%(1M)
Market Cap384.4B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio106.06
ROE68.0%
P/B Ratio14.04
Dividend Yield3.1%
JNJ
JNJ

Johnson & Johnson

$225.33
-0.9%(1M)
Market Cap542.4B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio26.19
ROE26.3%
P/B Ratio6.79
Dividend Yield2.3%
Performance Comparison

Historical returns across multiple timeframes

ABBV leads 5/8
ABBV

ABBV

AbbVie Inc.

+17.2%

1Y Return

JNJ

JNJ

Johnson & Johnson

+46.7%

1Y Return

ABBV
ABBV
JNJ
JNJ

Short Term

1M-6M

JNJ
-0.4%

Medium Term

YTD-1Y

JNJ
+27.8%

Long Term

3Y-10Y

ABBV
+133.0%

Valuation

Compare price multiples and valuation ratios

ABBV: 1JNJ: 4
MetricABBVJNJWinner
P/E Ratio

Price to earnings ratio

106.0626.19JNJ
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

6.125.63JNJ
P/B Ratio

Price to book ratio

14.046.79JNJ
P/FCF Ratio

Price to free cash flow ratio

18.4230.48ABBV
EV/EBITDA

Enterprise value to EBITDA

26.4717.02JNJ
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

ABBV: 3JNJ: 3
MetricABBVJNJWinner
Gross Margin

Gross profit margin

70.7%69.1%ABBV
Operating Margin

Operating profit margin

27.6%26.9%ABBV
Net Margin

Net profit margin

5.8%21.8%JNJ
ROE

Return on equity

68.0%26.3%ABBV
ROA

Return on assets

2.7%10.5%JNJ
ROIC

Return on invested capital

10.3%13.6%JNJ

Growth

Compare revenue and earnings growth rates

ABBV: 2JNJ: 4
MetricABBVJNJWinner
Revenue Growth (YoY)

Year-over-year revenue growth

8.6%6.0%ABBV
Revenue Growth (3Y)

3-year revenue CAGR

1.8%5.6%JNJ
Revenue Growth (5Y)

5-year revenue CAGR

6.0%2.7%ABBV
EPS Growth (YoY)

Year-over-year EPS growth

-0.8%90.5%JNJ
EPS Growth (3Y)

3-year EPS CAGR

-29.0%17.9%JNJ
EPS Growth (5Y)

5-year EPS CAGR

-2.7%14.9%JNJ

Balance Sheet & Risk

Compare financial stability and debt levels

ABBV: 0JNJ: 5
MetricABBVJNJWinner
Debt/Equity

Debt to equity ratio

2.650.22JNJ
Current Ratio

Current assets to current liabilities

0.801.03JNJ
Quick Ratio

Quick assets to current liabilities

0.680.77JNJ
Interest Coverage

EBIT to interest expense

5.9631.97JNJ
Beta

Stock volatility vs market

0.310.26JNJ
Summary
JNJ wins 3-0

Valuation

JNJ

Profitability

Tie

Growth

JNJ

Balance Sheet

JNJ

JNJ is more attractively valued. JNJ demonstrates better growth. JNJ has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into ABBV and JNJ with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/ABBV/vs/JNJ" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare ABBV vs JNJ on stockvs.app
</a>